Christine Miller

Pediatric infectious disease doctor @YaleMed. Researching #LongCOVID in children. Caring for kids with post-acute infection syndromes.

[Christine Miller @ChrisMillerDO]

@soundgmh @VirusesImmunity @jannamoen Our goal with the article was not to be comprehensive, but to illustrate a clear, recurring pattern across pathogens and time that shared highlight shared features of post-acute infection syndromes.

[Christine Miller @ChrisMillerDO]

Excited to share this article @VirusesImmunity and @jannamoen and I co-wrote. Long COVID is only the latest in a long pattern of post-acute infectious sequelae following epidemics. https://t.co/f8ZHFI2RTe

[Christine Miller @ChrisMillerDO]

@soundgmh @VirusesImmunity @jannamoen Kawasaki disease, while still not fully understood mechanistically, has well-established diagnostic criteria, and the same is true for MIS-C. We also have treatment options for both—nonspecific, yes, but still generally effective.

[Prof. Akiko Iwasaki @VirusesImmunity]

Check out our new review, "The lingering shadow of epidemics: post-acute sequelae across history" by Drs. Christine Miller and @jannamoen. We highlight historical accounts of post-acute infection syndromes (PAIS) through the centuries 👇🏼 #LongCOVID
https://t.co/gCS7nmVKUW

[Christine Miller @ChrisMillerDO]

Excited to share that Pediatric Long COVID week will be happening this year, July 21st-25th. Join if you can! #LongCovidKids #LongCovidAwareness

https://t.co/scooiWNeOL

[Christine Miller @ChrisMillerDO]

Excellent description and graphics from @nytimes of the spread of infectious diseases. https://t.co/Bb5LMzBHSX

[Prof. Akiko Iwasaki @VirusesImmunity]

Six critical steps that the health authorities should be taking now to mitigate the risks and prepare for avian flu pandemic by @cbarbermd. A wider range of antiviral medications (both broad and specific) is needed to combat all respiratory infections

https://t.co/bq56DNikaF

[Alex Lercher @alex_lercher]

Great Spotlight by @VirusesImmunity and @S_Tabachnikova on our recent publication in @ImmunityCP, where we studied antiviral innate immune memory in alveolar macrophages in the context of respiratory viral infections!

https://t.co/lQmqt2i7AB

[World Health Organization (WHO) @WHO]

#LongCOVID, or post #COVID19 condition, is a substantial and ongoing challenge to global health.​

Join this webinar for an update on global scenario of research on post COVID-19 condition, what we have learnt so far and initiatives to support patient care.

🗓️ TOMORROW, Wed., 20 November 2024
🕓 16h00 CET
📝Register https://t.co/Mc8C7WCmC2

🌏 The webinar will be repeated later in the week for other time zones

[Christine Miller @ChrisMillerDO]

Staph aureus, yeast, and Pseudomonas are all organisms that always warrant repeat cultures

[Christine Miller @ChrisMillerDO]

Sharing this article just published in JCM by several outstanding Yale colleagues. The study helps direct when and when not to obtain repeat blood cultures in pediatric patients. https://t.co/6PoWLLFh5v

[Tianyang Mao @tianyangmao]

Incredible work led by @MiyuMoriyama on unadjuvanted nasal boosters for influenza viruses! Important implications for eliciting immunological protection against avian flu via mucosal vaccination. Congrats to everyone involved in the study!

[Christine Miller @ChrisMillerDO]

Recent paper showing differences in CCL23 levels in pediatric LC compared to controls. #LongCovidKids
https://t.co/sST9ecSYjj

[Michael Peluso, MD @MichaelPelusoMD]

Excited to be visiting @VirusesImmunity at the 2nd @YaleCII symposium today to talk about #LongCovid - Where we are, where we need to go, and how we can get there.

[Prof. Akiko Iwasaki @VirusesImmunity]

Sharing this scoping review on "Post-Acute sequelae of COVID-19 in pediatric patients within the United States" by @ChrisMillerDO - an amazing @YalePediatrics infectious diseases fellow focused on research and treatment of #longcovidkids (1/)

https://t.co/MhmoZmZLU4